COVID-19 Trial Activated in Under a Week Through New Research Program
Cohen Veterans Bioscience (CVB), a leading non-profit research biotech dedicated to advancing brain health, is supporting the National Association of Veterans Research Education Foundation (NAVREF) and the new VA Office of Research and Development (ORD) led Partnered Research Program (PRP).
As an outcome of the Access to Clinical Trials (ACT) for Veterans initiative, the PRP increases veterans’ access to high-quality clinical trials to give Veterans access to world-class health solutions. CVB is lending support to NAVREF to help it expand its infrastructure, including the employment of clinical trial facilitators who will help expedite study start-up at VA trial sites.
The launch of the PRP has led to significant reforms in the VA clinical trial process. The most important of these reforms, allowing clinical trial sponsors to use commercial institutional review boards (IRBs), was finalized in March. As a result, when the COVID-19 pandemic hit, the VA was ready to help lead the clinical research response. Since its launch, the VA has launched trial sites in days, not months, including a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) on its COVID-19 trial.